Clinical trial
AngelMed for Early Recognition and Treatment of STEMI
NCT00781118 is registered in ClinicalTrials.gov with Angel Medical Systems as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- AngelMed for Early Recognition and Treatment of STEMI
- Lead sponsor
- Angel Medical Systems
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- December 31, 2008
- Completion date
- May 17, 2017
- Enrollment
- 1,020 (actual)
- Sites
- 95
Conditions
As the registry lists them; a condition with its own page is linked.
acute coronary syndrome, acute myocardial infarction (ami), coronary occlusion